Navigation Links
2013 China Human Immunoglobulin (pH4) for Intravenous Injection Industry Research Report
Date:11/12/2013

DUBLIN, November 12, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/3szzdk/2013_china_human) has announced the addition of the "2013 China Human Immunoglobulin (pH4) for Intravenous Injection Industry Research Report" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

This 2013 research report is a professional and in-depth research report on the Chinese Human Immunoglobulin (pH4) for Intravenous Injection industry. This report firstly discusses the definition, classification, industry chain and other related information of this industry.

It then reviews manufacturing technology, product specifications and summary statistics of 25 major Chinese manufacturers 2010-2016 giving details on capacity, production, supply, demand, shortage, selling price, cost, gross margin, production value and market share.

In the end, this report discusses the 200K Bottles/year project feasibility analysis and investment return analysis, and gives related research conclusions and development trend analysis of the Chinese Human Immunoglobulin (pH4) for Intravenous Injection industry.

Key Topics Covered:

Chapter One Human Immunoglobulin (pH4) for Intravenous Injection Industry Overview

Chapter Two Human Immunoglobulin (pH4) for Intravenous Injection Manufacturing Process and Cost Analysis

Chapter Three Human Immunoglobulin (pH4) for Intravenous Injection Production Supply Sales Demand Market Status and Forecast

Chapter Four Human Immunoglobulin (pH4) for Intravenous Injection Key Manufacturers Analysis

Chapter Five Human Immunoglobulin (pH4) for Intravenous Injection Project Investment Feasibility Analysis

Chapter Six Human Immunoglobulin (pH4) for Intravenous Injection Industry Research Conclusions

Companies Mentioned

- Banghe Pharmaceutical Co.,Ltd.
- Boya Biological (300294)
- CTBB
- Greencross(China)
- Guangdong Shuanglin Bio-pharmacy Co.,Ltd.
- Guangdong Weilun Biological Pharmaceutical Co.,Ltd.
- Guizhou Taibang Biological Products Co.,Ltd.
- Guizhou Zhongtai Biological S&T Co.,Ltd.
- Haikang Biological Products Co.,Ltd.
- Hualan Bio (002007)
- Hunan Unisplendour Guhan Nanyue-pharmaceutical Co.,Ltd. (000590)
- Lanzhou Institute of Biological Products Co.,Ltd.
- PAFC
- Ronsen Pharmaceutical
- Shanghai Institute of Biological Products Co.,Ltd.
- Shanghai RAAS (002252)
- Shanghai Xinxing Medicine Co.,Ltd.
- Shanxi Kangbao Biological Product Co.,Ltd.
- Shenzhen Weiwuguangming Biological Products Co.,Ltd.
- Sichuan Yuanda Shuyang Pharmaceutical Co.,Ltd.
- Tonrol Pharmaceutical
- Walvax Biotechnology Co.,Ltd. (300142) (Hebei Daan)
- Wuhan Institute of Biological Products Co.,Ltd.
- Wuhan Zhongyuan Ruide Biological Products Co.,Ltd.
- Xi'an Huitian Blood Products Co.,Ltd.

For more information visit http://www.researchandmarkets.com/research/3szzdk/2013_china_human.

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals


'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Top buyers including Atico, Coles Group Asia, Kmart, Staples, Office Depot and Target Australia pre-registered to attend Global Sources spring China Sourcing Fairs
2. CentraState and Freehold Radiology Group train physicians from China
3. Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.
4. ResearchMoz: Global and China 4A Zeolite Industry 2012 Deep Research Report - Market Research Report
5. China Biologic Products to Host Earnings Conference Call on May 9, 2012 at 8:00 a.m. EDT (NY)
6. China Biologic Products Reports Higher Results for the First Quarter 2012
7. China Pharma Holdings, Inc. Reports First Quarter 2012 Financial Results
8. Osteoporosis Drug Market- Global And China Market Analysis, Size, Trends And Forecast (2010-2015)
9. China Botanic Attends 67th PHARMCHINA Fair
10. Xiangxue Pharmaceuticals to Acquire Rights for a Promising Drug Candidate from Kinex Pharmaceuticals for the Greater China Territory
11. China Botanic Attends the 111th China Import and Export Fair
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017  DarioHealth ... and big data solutions, today announced that its MyDario product is expected ... local TV listings for when The Dr. Oz Show airs in your ... The nine-time Emmy ... ...
(Date:9/23/2017)... 2017 Janssen Biotech, Inc. (Janssen) announced today ... the U.S. Food and Drug Administration (FDA) for the ... the treatment of moderately to severely active rheumatoid arthritis ... are needed to further evaluate the safety of sirukumab ... "We are ...
(Date:9/19/2017)... HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that ... developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... ... Journey: From the Mountains to the Mission Field”: the story of a missionary couple ... From the Mountains to the Mission Field” is the creation of published author, Carole ... and currently teaches a class of ladies at her church, which she has taught ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated ... in breathing. Oral appliances can offer significant relief to about 75 percent of ...
(Date:10/12/2017)... Fla. (PRWEB) , ... October 12, 2017 , ... IsoComforter, ... therapy products, announced today the introduction of an innovative new design of the shoulder ... pad so you get maximum comfort while controlling your pain while using cold therapy. ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about ... intend to develop to enable prevention of a major side effect of chemotherapy ... especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as ...
(Date:10/12/2017)... ... , ... Leading pediatric oncology experts at Children’s National Health System ... of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by ... Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief of the ...
Breaking Medicine News(10 mins):